U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06821945) titled 'A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia' on Feb. 06.
Brief Summary: The objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
Schizophrenia
Intervention:
DRUG: BR5402A
Subjects take the investigational products once a day
DRUG: BR5402A-1
Subjects take the investigational products once a day
DRUG: BR5402B
Subjects take the investigational products once a day
DRUG: BR5402B-1
Subjects take the investi...